Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial
暂无分享,去创建一个
E. Leifer | D. Leaf | E. Hade | J. Hochman | P. Lawler | R. Zarychanski | E. Goligher | M. Neal | L. Kornblith | N. Smilowitz | H. Reynolds | B. McVerry | L. Castellucci | Anna Heath | Keri S. Kim | B. Hunt | Andrei L. Kindzelski | M. Cushman | Jeffrey S. Berger | M.N. Gong | Michael Farkouh